Paragon 28 Sells to Zimmer Biomet
The ongoing consolidation in the foot and ankle market is progressing steadily. In a January 28 company report, Zimmer Biomet (ZB) announced it has reached a definitive agreement to acquire all outstanding shares of common stock of Paragon 28 (P28), with the transaction reflecting an equity value of approximately $1.1 billion.
History of Paragon 28
Founded in 2010, Paragon 28 has concentrated on the foot and ankle market, consistently innovating and establishing a solid platform. In 2024, the company achieved sales of approximately $255 million, with year-over-year growth above the market average.
What’s next for ZB/P28
Integrating sales forces and company cultures is not for the weak of heart. The good news here is that P28 can instantly elevate ZB to a competitive position in foot and ankle.
Recent Posts
See AllThe " Same Rate for Same Service" concept argues that services should be paid equally, regardless of where they are provided. This...
David (niche bunion company Treace Medical Concepts ) takes on Goliath ( Stryker Corporation ) with a newly announced lawsuit , alleging...
Exactech, founded by orthopedic surgeon Dr. Bill Petty in 1985, evolved into a big player in the orthopedic space, achieving revenues of...
コメント